Leads Biolabs’ LBL-047 gains IND approval for autoimmune diseases

Sep. 22, 2025

Nanjing Leads Biolabs Co. Ltd. has received IND approval from the FDA for LBL-047, its first autoimmune therapeutic candidate to enter the clinic.

Today's news in brief

BioWorld

BioWorld briefs for June 23, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

Nankai University and Accendatech present new majusculamide D derivatives

BioWorld Science

Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...